Heart Failure in Cardiac Amyloidosis: Suspecting and Diagnosing Transthyretin Amyloid Cardiomyopathy in Underdiagnosed Populations at Risk for Heart Failure-Selected References

Selected References

Pdf Summary

The document contains a list of selected references related to cardiac amyloidosis. General reviews, guidelines, and consensus statements include articles such as the "Transthyretin cardiac amyloidosis" review by Porcari et al. and the "ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis" by Kitzelson et al. The document also includes recommendations for imaging in cardiac amyloidosis, with Part 1 focusing on evidence-based methods (Dorbala et al.) and Part 2 focusing on diagnostic criteria and utilization (Dorbala et al.). The "Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review" by Ruberg et al. provides an in-depth review of transthyretin amyloid cardiomyopathy. The "Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis" by Maurer et al. offers recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis.<br /><br />The document also covers basic science articles, such as the "Amyloid nomenclature 2022" update by Buxbaum et al. and the review on targeting protein aggregation for the treatment of degenerative diseases by Eisele et al.<br /><br />Additionally, references related to specific diagnostic techniques include echocardiography, cardiac magnetic resonance imaging, and bone scintigraphy. Articles such as "Echo parameters for differential diagnosis in cardiac amyloidosis" by Pagourelias et al., "Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography" by Phelan et al., and "Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis" by Fontana et al. provide insights into these imaging techniques.<br /><br />The document also features references related to specific treatments for cardiac amyloidosis, such as tafamidis, inotersen, patisiran, and eplontersen. Articles like the "Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy" by Maurer et al. and the "Efficacy and safety of inotersen treatment for patients with hereditary transthyretin amyloidosis" by Benson et al. discuss the effectiveness and safety of these treatments.<br /><br />Lastly, the document includes references on multidisciplinary care in cardiac amyloidosis, including articles on specialized amyloidosis centers and best practices in patient care.<br /><br />Overall, the document provides a comprehensive list of selected references covering various aspects of cardiac amyloidosis, including diagnosis, imaging techniques, treatment options, and multidisciplinary care.

Keywords

cardiac amyloidosis

Transthyretin cardiac amyloidosis

ACC expert consensus decision pathway

imaging in cardiac amyloidosis

Transthyretin amyloid cardiomyopathy

Expert consensus recommendations

Amyloid nomenclature

targeting protein aggregation

echocardiography

multidisciplinary care